Vivos Therapeutics, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year One
Vivos Therapeutics, Inc. (VVOS) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $823.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-08-14
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $823.00K.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $823.00K.
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $808.00K.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $279.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2026-06-30 | $823.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $823.00K 10-Q · filed 2026-05-20 |
| 2025-12-31 | $808.00K 10-K · filed 2026-04-15 |
| 2025-09-30 | $279.00K 10-Q · filed 2025-11-19 |
| 2025-06-30 | $279.00K 10-Q · filed 2025-08-19 |
| 2025-03-31 | $35.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $50.00K 10-K · filed 2025-03-31 |
| 2024-09-30 | $50.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $50.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $50.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $50.00K 10-K/A · filed 2024-07-30 |
| 2023-09-30 | $50.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $50.00K 10-Q · filed 2023-08-16 |
| 2023-03-31 | $50.00K 10-Q · filed 2023-06-08 |
| 2022-12-31 | $39.00K 10-K · filed 2023-03-30 |
| 2022-09-30 | $39.00K 10-Q · filed 2022-12-20 |
| 2022-06-30 | $39.00K 10-Q · filed 2022-12-20 |
| 2022-03-31 | $39.00K 10-Q/A · filed 2022-11-25 |
| 2021-12-31 | $39.00K 10-K · filed 2022-03-31 |
| 2021-09-30 | $48.39K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $128.80K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $166.87K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $262.28K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |